Corrigendum: Compound Dihuang Granule inhibits nigrostriatal pathway apoptosis in Parkinson's disease by suppressing the JNK/AP-1 pathway

Front Pharmacol. 2023 Dec 20:14:1320322. doi: 10.3389/fphar.2023.1320322. eCollection 2023.

Li Wang^{1

2}, Yu-Fang Yang¹, Long Chen³, Zhu-Qing He¹, Dian-Yong Bi¹, Lei Zhang¹, Yan-Wu Xu⁴, Jian-Cheng He¹

¹ Department of Diagnostics of Traditional Chinese Medicine, School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
² Experiment Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese, Shanghai, China.
³ Experiment Center for Science and Technology, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
⁴ Department of Biochemistry, School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2021.621359.].

Keywords: JNK/AP-1 pathway; Parkinson’s disease; apoptosis; compound Dihuang Granule; network pharmacology; traditional Chinese medicine.